The licensing pact adds a second so-called "triple agonist" to the Danish drugmaker's portfolio as competition with Lilly and ...

What drew you to pursue a career in oncology and what is it that inspires you most about working in this field?

Population-based analyses of new vaccination programmes provide robust real-world evidence for post-licensure vaccine evaluation. A 2023–24 vaccine effectiveness analysis of immunocompetent adults ...

In 2007 and 2008, Holmes conducted a study for Pfizer investigating the angiogenesis ... companies reagent that is used by LabCorp and many labs across the nation called, R&D Systems VEGF ELISA.

AstraZeneca signed a deal with Alteogen worth up to $1.35 billion for subcutaneous cancer drugs. Taiho Pharmacetical bought ...

Beqvez brings an inauspicious ending to a gene therapy that got its start more than a decade ago in the labs of Spark Therapeutics in Philadelphia. Pfizer's disclosure Friday that it is ending ...

and cloud data warehousing to Pfizer laboratory, clinical manufacturing, and clinical supply chain efforts. Pfizer teams in pharmaceutical development and clinical manufacturing hatch promising ...

A new precision oncology paper was published in Oncotarget, Volume 16, on March 12, 2025, titled “Worldwide Innovative ...

This is the latest sign of global healthcare giants doubling down on the market in recent years. Experts noted on Monday that ...

Elevai Labs (NASDAQ:ELAB – Get Free Report) and Arvinas (NASDAQ:ARVN – Get Free Report) are both small-cap multi-sector conglomerates companies, but which is the superior business? We will compare the ...

Recent spinoffs with good payouts include Kenvue, Carrier Global, Organon, Kontoor Brands, Phinia, and Sylvamo.

Adolescents with alopecia areata achieve hair regrowth with 80% or more of scalp coverage while taking the Janus kinase inhibitor baricitinib, a phase 3 study finds.